Literature DB >> 11578619

Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743.

K Varnäs1, H Hall, P Bonaventure, G Sedvall.   

Abstract

The distribution of 5-HT(1B) and 5-HT(1D) receptors in the human post mortem brain was examined using whole hemisphere autoradiography and the radioligand [(3)H]GR 125743. [(3)H]GR 125743 binding was highest in the substantia nigra and the globus pallidus. Lower levels were detected in the striatum, with the highest densities in the ventromedial parts. In the amygdala, the hippocampus, the septal region and the hypothalamus, lower [(3)H]GR 125743 binding was observed, reflecting low densities of 5-HT(1B/1D) receptors. In the cerebral cortex, binding was similar in most regions, although restricted parts of the medial occipital cortex were markedly more densely labeled. Binding densities were very low in the cerebellar cortex and in the thalamus. Two methods were used to distinguish between the two receptor subtypes, the first using ketanserin to block 5-HT(1D) receptors and the second using SB 224289 to inhibit 5-HT(1B) receptor binding. The autoradiograms indicated that in the human brain, the 5-HT(1B) receptor is much more abundant than the 5-HT(1D) receptor, which seemed to occur only in low amounts mainly in the ventral pallidum. Although [(3)H]GR 125743 is a suitable radioligand to examine the distribution of 5-HT(1B) receptors in the human brain in vitro, the selectivities of ketanserin and SB 224289 are not sufficiently high to give definite evidence for the occurrence of the 5-HT(1D) receptor in the human brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578619     DOI: 10.1016/s0006-8993(01)02823-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

Review 1.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

2.  Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach.

Authors:  Sjoerd J Finnema; Andrea Varrone; Tzung-Jeng Hwang; Christer Halldin; Lars Farde
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

3.  Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.

Authors:  Marie Deen; Anders Hougaard; Hanne Demant Hansen; Martin Schain; Agnete Dyssegaard; Gitte Moos Knudsen; Messoud Ashina
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

4.  Inverse changes in raphe and cortical 5-HT1B receptor availability after acute tryptophan depletion in healthy human subjects.

Authors:  Stephen R Baldassarri; Eunkyung Park; Sjoerd J Finnema; Beata Planeta; Nabeel Nabulsi; Soheila Najafzadeh; Jim Ropchan; Yiyun Huang; Jonas Hannestad; Kathleen Maloney; Zubin Bhagwagar; Richard E Carson
Journal:  Synapse       Date:  2020-05-07       Impact factor: 2.562

5.  5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro.

Authors:  K-Z Shen; S W Johnson
Journal:  Neuroscience       Date:  2007-12-08       Impact factor: 3.590

6.  OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Authors:  Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

7.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

8.  Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.

Authors:  Katarina Varnäs; Svante Nyberg; Per Karlsson; M Edward Pierson; Matts Kågedal; Zsolt Cselényi; Dennis McCarthy; Alan Xiao; Minli Zhang; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2011-01-15       Impact factor: 4.530

9.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

10.  Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans.

Authors:  Jean-Dominique Gallezot; Nabeel Nabulsi; Alexander Neumeister; Beata Planeta-Wilson; Wendol A Williams; Tarun Singhal; Sunhee Kim; R Paul Maguire; Timothy McCarthy; J James Frost; Yiyun Huang; Yu-Shin Ding; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.